{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-004253","form_type":"8-K","ticker":"ANIK","cik":"0000898437","company_name":"Anika Therapeutics, Inc.","filed_at":"2026-06-23T20:05:18+00:00","discovered_at":"2026-06-23T20:07:00.257037+00:00","generated_at":"2026-06-23T20:08:00.202906+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Anika shareholders approve share reserve increases for equity plans at annual meeting","bullets":["Stockholders approved amendment to 2017 Omnibus Incentive Plan, increasing reserved shares from 5,760,000 to 6,110,000 (350,000 share increase).","Stockholders approved amendment to 2021 Employee Stock Purchase Plan, increasing reserved shares from 200,000 to 400,000 (200,000 share increase).","Directors Gary P. Fischetti, John B. Henneman III, and Stephen D. Griffin elected as Class III directors until 2029 annual meeting.","Ratification of Deloitte & Touche as independent auditor for FY2026 passed: 11,136,590 for, 24,966 against, 34,111 abstain.","Advisory say-on-pay vote passed: 8,268,676 for, 1,093,946 against, 31,179 abstain; 1,801,866 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-004253","json":"https://secwatch.observer/filing/0001171843-26-004253.json","markdown":"https://secwatch.observer/filing/0001171843-26-004253.md","text":"https://secwatch.observer/filing/0001171843-26-004253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/898437/000117184326004253/0001171843-26-004253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/898437/000117184326004253/f8k_062326.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T20:08:00.202906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}